An open-label study of zoledronic acid (Aclasta 5 mg iv) in the treatment of ankylosing spondylitis. Issue 6 (12th February 2014) - Clunie, G P R; Ginawi, A; O'Conner, P; Bearcroft, P W; Garber, S J; Bhagat, S; Grainger, A; Gaston, J S H